Copyright Reports & Markets. All rights reserved.

Europe Pharmacovigilance and Drug Safety Software Market Report 2020

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Pharmacovigilance and Drug Safety Software Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 On Premise Software Market Performance (Volume)
      • 2.1.2 On-demand/Cloud based (SAAS) Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 On Premise Software Market Performance (Value)
      • 2.2.2 On-demand/Cloud based (SAAS) Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 BPOs Market Performance (Volume)
      • 3.1.2 CROs Market Performance (Volume)
      • 3.1.3 Pharma & Biotech Companies Market Performance (Volume)
      • 3.1.4 Others Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Sparta Systems, Inc.
      • 4.1.1 Sparta Systems, Inc. Profiles
      • 4.1.2 Sparta Systems, Inc. Product Information
      • 4.1.3 Sparta Systems, Inc. Pharmacovigilance and Drug Safety Software Business Performance
      • 4.1.4 Sparta Systems, Inc. Pharmacovigilance and Drug Safety Software Business Development and Market Status
    • 4.2 Oracle Corporation
      • 4.2.1 Oracle Corporation Profiles
      • 4.2.2 Oracle Corporation Product Information
      • 4.2.3 Oracle Corporation Pharmacovigilance and Drug Safety Software Business Performance
      • 4.2.4 Oracle Corporation Pharmacovigilance and Drug Safety Software Business Development and Market Status
    • 4.3 United BioSource Corporation
      • 4.3.1 United BioSource Corporation Profiles
      • 4.3.2 United BioSource Corporation Product Information
      • 4.3.3 United BioSource Corporation Pharmacovigilance and Drug Safety Software Business Performance
      • 4.3.4 United BioSource Corporation Pharmacovigilance and Drug Safety Software Business Development and Market Status
    • 4.4 Online Business Applications, Inc.
      • 4.4.1 Online Business Applications, Inc. Profiles
      • 4.4.2 Online Business Applications, Inc. Product Information
      • 4.4.3 Online Business Applications, Inc. Pharmacovigilance and Drug Safety Software Business Performance
      • 4.4.4 Online Business Applications, Inc. Pharmacovigilance and Drug Safety Software Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Europe Pharmacovigilance and Drug Safety Software Sales (K Units) and Market Share by Manufacturers 2014-2020
    • 5.2 Europe Pharmacovigilance and Drug Safety Software Revenue (M USD) and Market Share by Manufacturers 2014-2020
    • 5.3 Europe Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
    • 5.4 Europe Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Germany Market Performance for Manufacturers
      • 6.1.1 Germany Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.1.2 Germany Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.1.3 Germany Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.1.4 Germany Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.1.5 Market Concentration
    • 6.2 UK Market Performance for Manufacturers
      • 6.2.1 UK Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.2.2 UK Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.2.3 UK Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.2.4 UK Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.2.5 Market Concentration
    • 6.3 France Market Performance for Manufacturers
      • 6.3.1 France Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.3.2 France Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.3.3 France Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.3.4 France Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.3.5 Market Concentration
    • 6.4 Russia Market Performance for Manufacturers
      • 6.4.1 Russia Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.4.2 Russia Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.4.3 Russia Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.4.4 Russia Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.4.5 Market Concentration
    • 6.5 Benelux Market Performance for Manufacturers
      • 6.5.1 Benelux Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.5.2 Benelux Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.5.3 Benelux Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.5.4 Benelux Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.5.5 Market Concentration
    • 6.6 Italy Market Performance for Manufacturers
      • 6.6.1 Italy Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.6.2 Italy Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.6.3 Italy Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.6.4 Italy Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.6.5 Market Concentration
    • 6.7 Spain Market Performance for Manufacturers
      • 6.7.1 Spain Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.7.2 Spain Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.7.3 Spain Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.7.4 Spain Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Pharmacovigilance and Drug Safety Software Sales (K Units) and Share of Manufacturers 2014-2020
      • 6.8.2 Pharmacovigilance and Drug Safety Software Revenue (M USD) and Share of Manufacturers 2014-2020
      • 6.8.3 Pharmacovigilance and Drug Safety Software Price (USD/Unit) of Manufacturers 2014-2020
      • 6.8.4 Pharmacovigilance and Drug Safety Software Gross Margin of Manufacturers 2014-2020
      • 6.8.5 Market Concentration

    7 Europe Pharmacovigilance and Drug Safety Software Market Performance (Sales Point)

    • 7.1 Europe Pharmacovigilance and Drug Safety Software Sales (K Units) and Market Share by Regions 2014-2020
    • 7.2 Europe Pharmacovigilance and Drug Safety Software Revenue (M USD) and Market Share by Regions 2014-2020
    • 7.3 Europe Pharmacovigilance and Drug Safety Software Price (USD/Unit) by Regions 2014-2020
    • 7.4 Europe Pharmacovigilance and Drug Safety Software Gross Margin by Regions 2014-2020

    8 Development Trend for Regions (Sales Point)

    • 8.1 Europe Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.2 Germany Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.3 UK Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.4 France Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.5 Russia Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.6 Benelux Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.7 Italy Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020
    • 8.8 Spain Pharmacovigilance and Drug Safety Software Sales and Growth, Sales Value and Growth Rate2014-2020

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 BPOs Industry
    • 11.2 CROs Industry
    • 11.3 Pharma & Biotech Companies Industry
    • 11.4 Others Industry

    12 Market Forecast 2021-2026

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
      • 12.1.1 Europe Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
      • 12.1.2 Europe Pharmacovigilance and Drug Safety Software Sales (K Units) and Growth Rate 2021-2026
      • 12.1.3 Germany Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.4 UK Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.5 France Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.6 Russia Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.7 Benelux Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.8 Italy Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.1.9 Spain Pharmacovigilance and Drug Safety Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
      • 12.2.1 Overall Market Performance
      • 12.2.2 On Premise Software Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
      • 12.2.3 On-demand/Cloud based (SAAS) Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
    • 12.3 Sales Forecast by Application 2021-2026
      • 12.3.1 Overall Market Performance
      • 12.3.2 BPOs Sales and and Growth Rate 2021-2026
      • 12.3.3 CROs Sales and and Growth Rate 2021-2026
      • 12.3.4 Pharma & Biotech Companies Sales and and Growth Rate 2021-2026
      • 12.3.5 Others Sales and and Growth Rate 2021-2026
    • 12.4 Price (USD/Unit) and Gross Profit Forecast
      • 12.4.1 Europe Pharmacovigilance and Drug Safety Software Price (USD/Unit) Trend 2021-2026
      • 12.4.2 Europe Pharmacovigilance and Drug Safety Software Gross Profit Trend 2021-2026

    13 Conclusion

    In this report, the Pharmacovigilance and Drug Safety Software market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
    Sales and revenue by type/application from 2014-2026.
    Industry chain, market trend, downstream and upstream information is also included.

    Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Pharmacovigilance and Drug Safety Software for these regions, from 2014 to 2026 (forecast), including
    Germany
    UK
    France
    Russia
    Benelux
    Italy
    Spain

    Europe Pharmacovigilance and Drug Safety Software market competition by top manufacturers/players, with Pharmacovigilance and Drug Safety Software sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Sparta Systems, Inc.
    Oracle Corporation
    United BioSource Corporation
    Online Business Applications, Inc.
    ...

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    On Premise Software
    On-demand/Cloud based (SAAS)

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Pharmacovigilance and Drug Safety Software for each application, including
    BPOs
    CROs
    Pharma & Biotech Companies
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now